Angharad Kolator Baldwin

Angharad completed an integrated Master's in molecular biology at the University of Sheffield. After working in the editorial team for the Journal of Gemmology, she went on to be a reporter for a trade pharmaceutical magazine. She joined the press team at Cancer Research UK in October 2018, writing national press releases as well as creating content for the science blog.

Showing 4 out of 4 results

Wales lifting Six Nations trophy in 2019.

Health & Medicine

Should alcohol marketing be dropped from televised sport?

During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage. During the 2019 Six Nations,122.4 billion Guinness-related branded impressions were delivered to the UK population who watched the coverage.

by Angharad Kolator Baldwin | Analysis | 27 August 2021

27 August 2021

A genderqueer person having a pelvic exam

Health & Medicine

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening. Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

by Angharad Kolator Baldwin | Analysis | 18 May 2021

18 May 2021

Health & Medicine

COVID-19: Keeping cancer patients on clinical trials

We look at some of the work being done to keep people with cancer on clinical trials during the coronavirus pandemic. We look at some of the work being done to keep people with cancer on clinical trials during the coronavirus pandemic.

by Angharad Kolator Baldwin | Analysis | 15 June 2020

15 June 2020

This entry is part 6 of 6 in the series COVID-19 research

Science & Technology

Blood tests: using blood to detect cancer early

The idea of taking a small vial of blood and being able to detect cancer at its earliest and most treatable stages is an attractive one. The idea of taking a small vial of blood and being able to detect cancer at its earliest and most treatable stages is an attractive one.

by Angharad Kolator Baldwin | Analysis | 4 December 2019

4 December 2019

This entry is part 4 of 4 in the series Detecting cancer early

Cancer News

Angharad Kolator Baldwin

Should alcohol marketing be dropped from televised sport?

Research shows one size doesn’t fit all for cervical screening in the trans and non-binary community

COVID-19: Keeping cancer patients on clinical trials

Blood tests: using blood to detect cancer early